NASDAQ: EYPT
Eyepoint Pharmaceuticals Inc Earnings Dates, Reports, Calls

Eyepoint Pharmaceuticals earnings were -$130.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest EYPT earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$41.4M, up 41% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EYPT reported annual earnings of -$130.9M, with 84.9% growth. The next EYPT earnings date is May 6, 2025.

EYPT earnings history

Current Revenue
$43.3M
Current Earnings
-$130.9M
Current Profit Margin
-302.4%

EYPT Return on Equity

Current Company
-50.7%
Current Industry
-1.4%
Current Market
34.2%
EYPT's Return on Equity (-50.7%)... subscribe to Premium to read more.
High Return on Equity Performance

EYPT undefined

Current Company
-38.1%
Current Industry
0.2%
EYPT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EYPT announces earnings.

EYPT undefined

Current Company
-35.4%
Current Industry
6.7%
EYPT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EYPT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EYPT-$129.23M-$130.87MN/A-$2.32
AUTL-$197.41M-$220.66MN/A-$0.86
PRTCN/AN/AN/AN/A
ERAS-$157.85M-$161.65MN/A-$0.69
STOK-$97.18M-$88.98MN/A-$1.65

EYPT earnings dates

Next earnings date
May 6, 2025

Eyepoint Pharmaceuticals Earnings Reports & History FAQ

What were Eyepoint Pharmaceuticals's earnings last quarter?

On EYPT's earnings call on Invalid Date, Eyepoint Pharmaceuticals (NASDAQ: EYPT) reported Q4 2024 earnings per share (EPS) of -$0.65, up 103.13% year over year. Total EYPT earnings for the quarter were -$41.40 million. In the same quarter last year, Eyepoint Pharmaceuticals's earnings per share (EPS) was -$0.32.

If you're new to stock investing, here's how to buy Eyepoint Pharmaceuticals stock.

When does Eyepoint Pharmaceuticals report earnings?

The next EYPT earnings call is Invalid Date. Add EYPT to your watchlist to be reminded of Eyepoint Pharmaceuticals's next earnings date.

Is Eyepoint Pharmaceuticals profitable or losing money?

As of the last Eyepoint Pharmaceuticals earnings report, Eyepoint Pharmaceuticals is currently losing money. Eyepoint Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$130.87 million, a 84.86% increase year over year.

What was EYPT's earnings growth in the past year?

As of Eyepoint Pharmaceuticals's earnings date in Invalid Date, Eyepoint Pharmaceuticals's earnings has grown year over year. EYPT earnings in the past year totalled -$130.87 million.

What are Eyepoint Pharmaceuticals's earnings expectations?

The current EPS estimate for Eyepoint Pharmaceuticals's earnings report in Invalid Date is -$0.41.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.